NCT06163339

Brief Summary

Studies show that the mental health of children may have deteriorated in recent decades. In Sweden, several national initiatives have been implemented to develop and strengthen interventions for children's mental health. One of these initiatives involves enhancing the first line of primary care for children with mental health issues, whose mission is to provide early intervention, i.e., support for mild to moderate mental health problems. The responsibility for children with moderate to severe mental health issues lies with child and adolescent psychiatry. Research indicates that children with a migration background, to a lesser extent than native-born children, have contact with both the first line of mental health care and child and adolescent psychiatry. There is also research showing that when newly arrived individuals do seek care, they may receive poorer quality care than others and, for example, may be misunderstood. From the perspective of equal healthcare, this is a significant shortcoming. In our study, the investigators address differences between healthcare providers and families based on cultural factors as a possible reason for the lack of equality in healthcare. In the study, the investigators aim to evaluate whether the Cultural Formulation Interview (CFI) improves the connection between healthcare providers and families and increases the family's involvement in treatment, ultimately leading to better mental health for the child. The method can be said to aim at enhancing the assessment, compliance, and treatment that are currently available within healthcare.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
248

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 8, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 15, 2023

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment Credibility Scale

    The scale includes four statements (for example, "So far, how well do you think this care seems to fit your problems?"). The informant can respond on a Likert scale ranging from 0 to 10.

    Two-three weeks after the baseline assessment

Secondary Outcomes (3)

  • KIDSCREEN-10

    Three months after the baseline assessment

  • The Revised Child Anxiety and Depression Scale

    Three months after the baseline assessment

  • Working Alliance Inventory

    Three months after the baseline assessment

Study Arms (2)

CFI + Usual Care

EXPERIMENTAL

About half of participants who are allocated to a person who works with the CFI during the trial.

Other: Cultural Formulation Interview

Usual Care

NO INTERVENTION

About half of participants who are allocated to a person who do not work with the CFI during the trial (i.e., usual care).

Interventions

Usual Care is enhanced with the Cultural Formulation Interview (CFI) aimed at strengthening assessment and treatment adherence

Also known as: CFI
CFI + Usual Care

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Study Part
  • Children between the ages of 6-14
  • Families seeking care at any of the participating clinics
  • Families assessed as suitable for interventions at the clinic where they seek care.
  • Study Part 2
  • Caregivers who have consented to participate in Part 1 and have been interviewed using CFI as part of the study
  • Healthcare providers/personnel who have used CFI as part of Part 1.

You may not qualify if:

  • Study Part 1
  • Children who have not yet turned 6 years old and individuals aged 15 and above
  • The child is assessed as not suitable for interventions at the clinic where they seek care.
  • Study Part 2
  • Caregivers who have not consented to participate in Part 1.
  • Caregivers who have not been interviewed using CFI as part of the study.
  • Healthcare providers/personnel who have not used CFI as part of Part 1.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Solna, 171 65, Sweden

Location

MeSH Terms

Interventions

chemotactic factor inactivator

Study Officials

  • Christina Dalman, Professor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Johan Åhlén, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 15, 2023

First Posted

December 8, 2023

Study Start

December 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

December 8, 2023

Record last verified: 2023-11

Locations